Provided by Tiger Trade Technology Pte. Ltd.

Progyny

27.35
+0.27001.00%
Post-market: 27.350.00000.00%19:30 EDT
Volume:1.24M
Turnover:34.14M
Market Cap:2.10B
PE:30.15
High:27.77
Open:27.45
Low:27.32
Close:27.08
52wk High:33.07
52wk Low:16.10
Shares:76.73M
Float Shares:70.79M
Volume Ratio:1.10
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9071
EPS(LYR):0.6500
ROE:16.24%
ROA:10.14%
PB:4.63
PE(LYR):42.08

Loading ...

Progyny Outlook Q3 Adjusted EPS USD 0.5-0.52

THOMSON REUTERS
·
Aug 07

Earning Preview: Progyny revenue expected to increase by 8.94%, institutions lean positive on near-term earnings resilience

Earnings Agent
·
Jul 31

Progyny Shares Drop After Downgrade From Barclays

MT Newswires Live
·
Jul 29

Progyny Cut to Equal-Weight from Overweight by Barclays

Dow Jones
·
Jul 28

Barclays Downgrades Progyny to Equalweight From Overweight, Adjusts Price Target to $34 From $27

MT Newswires Live
·
Jul 28

Progyny : Barclays Cuts to Equal-Weight from Overweight

THOMSON REUTERS
·
Jul 28

Progyny downgraded to Equal Weight from Overweight at Barclays

TIPRANKS
·
Jul 28

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Summit Therapeutics (SMMT) and Progyny (PGNY)

TIPRANKS
·
Jul 24

Progyny is Maintained at Buy by BTIG

Dow Jones
·
Jul 24

Progyny to Report Q2 Results After Market Close Aug. 6, Host Conference Call

Reuters
·
Jul 24

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

THOMSON REUTERS
·
Jul 24

Progyny Inc : Leerink Partners Raises Target Price to $38 from $30

THOMSON REUTERS
·
Jul 22

Progyny is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 21

Progyny price target raised to $36 from $30 at Canaccord

TIPRANKS
·
Jul 21

Progyny COO Melissa B. Cummings Disposes of Common Shares Worth $109,393.58

Reuters
·
Jul 17

Progyny is Maintained at Overweight by Keybanc

Dow Jones
·
Jul 13

Progyny price target raised to $35 from $30 at KeyBanc

TIPRANKS
·
Jul 13

Does Progyny’s (PGNY) Index Exit Quietly Recast Its Long‑Term Competitive Positioning?

Simply Wall St.
·
Jun 30

Progyny Is Maintained at Buy by Truist Securities

Dow Jones
·
Jun 23

Truist Adjusts Price Target on Progyny to $33 From $30, Maintains Buy Rating

MT Newswires Live
·
Jun 22